Literature DB >> 15923649

Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing.

Yuji Shirakata1, Rina Kimura, Daisuke Nanba, Ryo Iwamoto, Sho Tokumaru, Chie Morimoto, Koichi Yokota, Masanori Nakamura, Koji Sayama, Eisuke Mekada, Shigeki Higashiyama, Koji Hashimoto.   

Abstract

Members of the epidermal growth factor (EGF) family are the most important growth factors involved in epithelialization during cutaneous wound healing. Heparin-binding EGF-like growth factor (HB-EGF), a member of the EGF family, is thought to play an important role in skin wound healing. To investigate the in vivo function of HB-EGF in skin wound healing, we generated keratinocyte-specific HB-EGF-deficient mice using Cre/loxP technology in combination with the keratin 5 promoter. Studies of wound healing revealed that wound closure was markedly impaired in keratinocyte-specific HB-EGF-deficient mice. HB-EGF mRNA was upregulated at the migrating epidermal edge, although cell growth was not altered. Of the members of the EGF family, HB-EGF mRNA expression was induced the most rapidly and dramatically as a result of scraping in vitro. Combined, these findings clearly demonstrate, for the first time, that HB-EGF is the predominant growth factor involved in epithelialization in skin wound healing in vivo and that it functions by accelerating keratinocyte migration, rather than proliferation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15923649     DOI: 10.1242/jcs.02346

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  82 in total

1.  The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release.

Authors:  Robin N Prince; Eric R Schreiter; Peng Zou; H Steven Wiley; Alice Y Ting; Richard T Lee; Douglas A Lauffenburger
Journal:  J Cell Sci       Date:  2010-06-08       Impact factor: 5.285

Review 2.  Skin wound healing modulation by macrophages.

Authors:  Mathieu P Rodero; Kiarash Khosrotehrani
Journal:  Int J Clin Exp Pathol       Date:  2010-07-25

Review 3.  The skinny on Slug.

Authors:  Stephanie H Shirley; Laurie G Hudson; Jing He; Donna F Kusewitt
Journal:  Mol Carcinog       Date:  2010-10       Impact factor: 4.784

4.  Hair-cycle dependent differential expression of ADAM 10 and ADAM 12: An immunohistochemical analysis in human hair follicles in situ.

Authors:  Shin-Taek Oh; Baik-Kee Cho; Anja Schramme; Paul Gutwein; Wolfgang Tilgen; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2009-01

5.  Epithelial separation theory for post-tonsillectomy secondary hemorrhage: evidence in a mouse model and potential heparin-binding epidermal growth factor-like growth factor therapy.

Authors:  Daniel M Beswick; Chloe Santa Maria; Noel F Ayoub; Robson Capasso; Peter Luke Santa Maria
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-29       Impact factor: 2.503

Review 6.  Regenerative Scar-Free Skin Wound Healing.

Authors:  Mehri Monavarian; Safaa Kader; Seyedsina Moeinzadeh; Esmaiel Jabbari
Journal:  Tissue Eng Part B Rev       Date:  2019-08       Impact factor: 6.389

Review 7.  Trafficking of epidermal growth factor receptor ligands in polarized epithelial cells.

Authors:  Bhuminder Singh; Robert J Coffey
Journal:  Annu Rev Physiol       Date:  2013-11-08       Impact factor: 19.318

8.  Metalloproteinase-mediated, context-dependent function of amphiregulin and HB-EGF in human keratinocytes and skin.

Authors:  Stefan W Stoll; Jessica L Johnson; Ajay Bhasin; Andrew Johnston; Johann E Gudjonsson; Laure Rittié; James T Elder
Journal:  J Invest Dermatol       Date:  2010-01       Impact factor: 8.551

9.  Free edges in epithelial cell sheets stimulate epidermal growth factor receptor signaling.

Authors:  Ethan R Block; Michael A Tolino; Jennifer S Lozano; Kira L Lathrop; Rebecca S Sullenberger; Abigail R Mazie; Jes K Klarlund
Journal:  Mol Biol Cell       Date:  2010-05-12       Impact factor: 4.138

10.  Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma.

Authors:  Hiromitsu Hatakeyama; Haixia Cheng; Pamela Wirth; Ashley Counsell; Samuel R Marcrom; Carey Burton Wood; Paula R Pohlmann; Jill Gilbert; Barbara Murphy; Wendell G Yarbrough; Deric L Wheeler; Paul M Harari; Yan Guo; Yu Shyr; Robbert J Slebos; Christine H Chung
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.